Parallel import is an important mechanism of competitive relations existence

Lubov Hryhorivna Kuzmenko, National University of Kyiv-Mohyla Academy


Author's ORCID identifiers:


Abstract


The article discusses the problems of introduction of parallel import of medicines. The article reveals the problematic and unresolved issues regarding the introduction of parallel import mechanism as a way of implementing the principles of free trade and free competition. It proves the need for a more transparent and effective mechanism for implementation of parallel imports of medicines. It examines some possible ways to improve implementation of parallel import of pharmaceutical products and to ensure its economic availability to consumers as an important mechanism for the existence of a competitive market for medicines. 

The author describes a possibility of legal justification for parallel import, which appeared with the concept’s development of international exhaustion of intellectual property, which is used for the following purposes: restriction of monopolistic activity; preventing the separation of the market; ensuring the free circulation of goods on the market. The suggestions are made for the development of transparent and clear procedures for admission of medicines to the market, which would eliminate the arbitrary approach, the emergence of a “preferred distributor” and, as a consequence a possible corruption component.


Keywords


parallel import; competition; medicines; pharmaceutical market; prices.

References


Potekhina, V. A. (2008). Intellectualna vlasnist [Intellectual property]. Kyiv: TSUL.

Androshchuk, G. (2013). Zashita intellectualnoy sobstvennosti tamozhennyvy organamy: opyt SSHA i Europeyskogo Soyuza [Protection of intellectual property rights by customs authorities: the US experience and the European Union]. Promyshlennaya sobstvennost, 12, 54–65.

Trofimova, E. Differentsirovannoe tsenoobrazovanye na pharmaceuticheskom rynke v razreze razlichnykh stran [Differential pricing in the pharmaceutical market in the context of various countries]. Retrieved from http://www.remedium.ru/section/detail.php?ID=57707.

Rishennia Europeyskoy Commissii vid 15.06.2005 stosovno Astra Zeneca [The European Commission’s decision dated 15.06.2005 about Astra Zeneca] (2005, June 15). Retrieved from http://cyberleninka.ru/article/n/novye-tendentsii-v-razvitiiprava-konkurentsii-es-reshenie-po-delu-astrazeneca.

Ozolina, I. G. (2006). Pravovoyе regulirovanuye parallelnogo importa [Legal regulation of parallel way]. Retrieved from http://rbis.su/article.php?article=663.

Ugoda pro torgovelni aspekty prav intelektualnoyi vlasnosti [The agreement on trade-related aspects of intellectual property rights]. (1994). Mizhnarodnuy document. SOT. Retrieved from http://zakon0.rada.gov.ua/laws/show/981_018/page5.

Polyakova, D. (2010). Intellectualnaya sobstvennost v pharmaciyi: problemy i perspectuvu [Intellectual property in pharmacy: problems and prospects]. Gazeta “Apteka”, 751. Retrieved from http://www.apteka.ua/article/48631.


Citations

Cite this article in APA format:

Kuzmenko, L. (2016). Parallel import is an important mechanism of competitive relations existence. Scientific Papers NaUKMA. Economics, 1(1), 95-100.

Cite this article in GOST format:

Kuzmenko Lubov. Parallel import is an important mechanism of competitive relations existence // Scientific Papers NaUKMA. Economics. - 2016. - Vol. 1, N. 1. - P. 95-100.

Altmetrics

Refbacks

  • There are currently no refbacks.
ISSN: 2519-4747 (online); 2519-4739 (print)